XML 85 R74.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss Per Share - Narrative (Details) - $ / shares
3 Months Ended 6 Months Ended
Dec. 07, 2021
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Feb. 11, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Options outstanding (in shares)     957,569   482,000  
Weighted-average exercise price average exercise price (in usd per share)     $ 8.18   $ 9.99  
Exercise price (usd per shares)     $ 11.50      
Debt conversion, converted instrument, shares issued (in shares) 17,391,304   18,844,600      
Debt instrument, convertible, conversion price (in usd per shares) $ 11.50   $ 10.61      
Maximum number of shares per employee (in shares)     477,280      
Antidilutive shares (in shares)   0   0    
Restricted Stock Units (RSUs)            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Shares outstanding (in shares)     3,035,461      
Performance Shares            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Shares outstanding (in shares)     150,000      
Private warrants            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Number of securities called by warrant (in shares)     319,893      
Exercise price (usd per shares)     $ 11.50   $ 11.50  
Public Warrants            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Number of securities called by warrant (in shares)     12,005,879     1
Exercise price (usd per shares)           $ 11.50